Drew Pomeranz allows just one hit in rehab debut

2 Comments

A’s starter Drew Pomeranz made his minor league rehab debut on Saturday night with the Triple-A Sacramento River Cats. And it was promising.

The left-hander struck out seven, walked none, and yielded only one hit — a solo home run — over four strong innings, throwing 37 of 53 pitches for strikes.

Pomeranz — who fractured his right (non-throwing hand in June when he punched a wooden chair out of frustration — should be ready to rejoin the Athletics’ active roster after one or two more rehab outings.

But his rotation spot was recently filled by the Jeff Samardzija and Jason Hammel trade, and Oakland is expected to leave him at Sacramento as an emergency starter for the stretch run. Susan Slusser of the San Francisco Chronicle wonders if the A’s front office might dangle Pomeranz in a deadline deal for a second baseman.

The 25-year-old had a 2.91 ERA in 55 2/3 innings before the injury.

Report: Phillies moving in on a deal with Tommy Hunter

Victor Decolongon/Getty Images
Leave a comment

Update (8:40 PM ET): Joel Sherman of the New York Post reports that Hunter’s contract with the Phillies is for two years.

*

There’s been a bit of confusion at the Winter Meetings. First, ESPN’s Buster Olney reported that the Phillies were close to signing free agent reliever Addison Reed. That report was then disputed by Jon Heyman of FanRag Sports. Matt Gelb of the Philadelphia Inquirer then reported that not only do the Phillies not have a deal with Reed, they’re actually moving in on a deal with free agent pitcher Tommy Hunter. Ken Rosenthal of The Athletic backed up Gelb’s report, as did Todd Zolecki of MLB.com.

Hunter, 31, spent the past season with the Rays, posting a 2.61 ERA with a 64/14 K/BB ratio across 58 2/3 innings. The right-hander, a veteran of 10 seasons in the majors, should be a good addition to the Phillies’ bullpen, which also recently added Pat Neshek. Neshek and Hunter will likely work the innings just ahead of closer Hector Neris.

As for Reed, well, who knows.